Related Experiment Videos

Mouse mammary tumor virus-mediated T-cell receptor negative selection in HLA-DRA transgenic mice

D M Altmann1, K Takács, J Trowsdale

  • 1Transplantation Biology Section, Clinical Research Centre, Harrow, London, England.

Human Immunology
|July 1, 1993
PubMed

Insights

Mouse superantigens, interacting with MHC class II molecules, delete specific T cells. Human DR alpha chains can substitute for mouse H-2E, but the beta chain

Area of Science:

  • Immunology
  • T-cell biology
  • MHC class II interactions

Background:

  • Mouse mammary tumor virus (Mtv) gene products act as superantigens.
  • Superantigens mediate T-cell deletion by binding to MHC class II molecules.
  • Previous studies showed human DR alpha can substitute for mouse E alpha in T-cell deletion.

Purpose of the Study:

  • To comprehensively analyze the interaction of human DR alpha/mouse E beta pairs with Mtv integrants.
  • To investigate the role of MHC class II alpha and beta chains in superantigen-induced T-cell deletion.
  • To determine the critical chain for superantigen binding and T-cell selection.

Main Methods:

  • Generation of transgenic mice expressing human DR alpha/mouse E beta.
  • Analysis of T-cell receptor V beta usage in transgenic mice.
  • Assessment of negative selection of T cells in response to Mtv superantigens.

Main Results:

  • Transgenic DR alpha/E beta efficiently interacted with Mtv-7, deleting V beta 6+ and V beta 7+ T cells.
  • Deletion of V beta 11+ T cells by Mtv-8 and -9 was less efficient with DR alpha compared to H-2Ea.
  • The beta chain identity appears critical for superantigen interaction and T-cell deletion.

Conclusions:

  • The beta chain of MHC class II molecules plays a critical role in superantigen specificity.
  • While the alpha chain influences superantigen interaction, the beta chain dictates the selection outcome.
  • These findings advance understanding of T-cell development and immune tolerance.

Related Concept Videos